Aktienanalyse zu Onemednet Corp (ONMD)ONMDOnemednet Corp

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets. It operates in the Industrials sector (COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH industry).

Onemednet Corp is not a good buy right now due to its current price of 0.58, which is significantly down 52.46% year-to-date. The stock shows a low RSI of 35.949, indicating it is oversold, but the negative catalysts, including a 19.42% decline over the last 20 days, suggest continued weakness. Additionally, the company has a concerning net income loss of -2,172,000 USD in the most recent quarter, which raises significant risk for investors.